Topoisomerase I inhibitor SN-38 effectively attenuates growth of human non-small cell lung cancer cell lines in vitro and in vivo.
about
Reprogramming ovarian and breast cancer cells into non-cancerous cells by low-dose metformin or SN-38 through FOXO3 activationDual-targeting hybrid nanoparticles for the delivery of SN38 to Her2 and CD44 overexpressed human gastric cancer.Combined efficacy and mechanism of trifluridine and SN-38 in a 5-FU-resistant human colorectal cancer cell lines.A novel oral camptothecin analog, gimatecan, exhibits superior antitumor efficacy than irinotecan toward esophageal squamous cell carcinoma in vitro and in vivo.Andrographolide potentiates the antitumor effect of topotecan in acute myeloid leukemia cells through an intrinsic apoptotic pathway.
P2860
Topoisomerase I inhibitor SN-38 effectively attenuates growth of human non-small cell lung cancer cell lines in vitro and in vivo.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Topoisomerase I inhibitor SN-3 ...... ll lines in vitro and in vivo.
@ast
Topoisomerase I inhibitor SN-3 ...... ll lines in vitro and in vivo.
@en
type
label
Topoisomerase I inhibitor SN-3 ...... ll lines in vitro and in vivo.
@ast
Topoisomerase I inhibitor SN-3 ...... ll lines in vitro and in vivo.
@en
prefLabel
Topoisomerase I inhibitor SN-3 ...... ll lines in vitro and in vivo.
@ast
Topoisomerase I inhibitor SN-3 ...... ll lines in vitro and in vivo.
@en
P2093
P2860
P1476
Topoisomerase I inhibitor SN-3 ...... ll lines in vitro and in vivo.
@en
P2093
Deryl Troyer
Dharmendra Kumar Maurya
Masaaki Tamura
Rie Ayuzawa
P2860
P356
10.1615/JENVIRONPATHOLTOXICOLONCOL.V30.I1.10
P577
2011-01-01T00:00:00Z